Skip to main content

Table 3 Univariate and multivariate analyses for coronary artery stenosis (CAS)

From: The Relationship between Pulse Wave Velocity and Coronary Artery Stenosis and Percutaneous Coronary Intervention: a retrospective observational study

Variable

Univariate analysis

Multivariate analysis

Exp(B)

OR (95% CI)

p-value

Exp(B)

OR (95% CI)

p-value

Total population

 Age

0.995

0.983–1.007

0.403

   

 Male

1.148

0.896–1.470

0.276

   

 BMI

0.995

0.956–1.036

0.808

   

 Smoking

0.951

0.730–1.237

0.706

   

 Hypertension

0.840

0.659–1.071

0.159

   

 Diabetes mellitus

0.812

0.608–1.085

0.159

   

 Dyslipidemia

1.184

0.930–1.509

0.171

   

 CKD

1.013

0.767–1.339

0.926

   

 RAS inhibitor

0.843

0.658–1.080

0.177

0.680

0.497–0.931

0.016

 Beta-blocker

1.340

0.991–1.811

0.057

   

 CCB

1.222

0.941–1.586

0.132

   

 Statin

1.131

0.885–1.445

0.325

1.477

1.084–2.014

0.014

 SBP

1.004

0.996–1.011

0.356

   

 DBP

0.977

0.965–0.988

<0.001

0.951

0.935–0.967

<0.001

 PP

1.023

1.013–1.034

<0.001

   

 cSBP

0.999

0.993–1.006

0.876

1.021

1.008–1.033

0.001

 baPWV

1.001

1.000–1.001

<0.001

1.075

1.021–1.133

0.006

 ABI

0.202

0.053–0.774

0.020

0.094

0.019–0.468

0.004

 AIx@75

0.990

0.980–1.001

0.064

0.976

0.963–0.989

<0.001

Patients without prior PCI history

 Age

1.001

0.987–1.014

0.895

   

 Male

1.035

0.777–1.378

0.814

   

 BMI

0.980

0.935–1.027

0.390

   

 Smoking

1.021

0.749–1.393

0.894

   

 Hypertension

0.796

0.599–1.059

0.118

0.667

0.462–0.964

0.031

 Diabetes mellitus

0.950

0.658–1.371

0.783

   

 Dyslipidemia

1.176

0.864–1.602

0.303

   

 CKD

1.176

0.836–1.655

0.352

   

 RAS inhibitor

0.806

0.586–1.108

0.183

   

 Beta-blocker

1.305

0.839–2.029

0.237

   

 CCB

1.208

0.878–1.662

0.247

1.552

1.032–2.333

0.035

 Statin

1.100

0.790–1.532

0.573

   

 SBP

1.001

0.993–1.010

0.762

   

 DBP

0.974

0.961–0.987

<0.001

0.952

0.933–0.971

<0.001

 PP

1.022

1.010–1.034

<0.001

   

 cSBP

0.998

0.990–1.005

0.528

1.016

1.001–1.030

0.034

 baPWV

1.001

1.000–1.001

<0.001

1.106

1.039–1.177

0.002

 ABI

0.123

0.024–0.621

0.011

0.039

0.006–0.273

0.001

 AIx@75

0.990

0.978–1.002

0.091

0.979

0.963–0.995

0.010

Patients with prior PCI history

 Age

0.972

0.948–0.997

0.026

   

 Male

1.510

0.898–2.539

0.120

   

 BMI

1.038

0.959–1.123

0.355

   

 Smoking

0.792

0.480–1.307

0.361

   

 Hypertension

0.928

0.578–1.488

0.756

   

 Diabetes mellitus

0.575

0.352–0.937

0.027

0.556

0.318–0.970

0.039

 Dyslipidemia

1.113

0.581–2.132

0.747

   

 CKD

0.718

0.440–1.174

0.187

   

 RAS inhibitor

0.735

0.450–1.198

0.217

   

 Beta-blocker

1.340

0.842–2.132

0.217

   

 CCB

1.205

0.757–1.919

0.433

   

 Statin

1.066

0.559–2.033

0.847

   

 SBP

1.010

0.995–1.026

0.196

   

 DBP

0.983

0.961–1.006

0.142

0.953

0.923–0.984

0.003

 PP

1.029

1.008–1.049

0.005

   

 cSBP

1.005

0.992–1.018

0.465

1.032

1.010–1.054

0.004

 baPWV

1.000

1.000–1.001

0.256

   

 ABI

0.640

0.058–7.095

0.716

   

 AIx@75

0.992

0.972–1.011

0.401

0.971

0.947–0.996

0.024

  1. RAS inhibitor refers to ACE inhibitors or ARBs
  2. CKD chronic kidney disease, OR odds ratio, 95% CI 95% confidence interval